SCHEMBL11278322

SCHEMBL11278322

CSc1nncc(-c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.58
▸ CYP1A2 P05177 2/20 0.58
▸ GAA P10253 2/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ LMNA P02545 1/20 0.54
▸ IDO1 P14902 1/20 0.47
▸ CTSS P25774 2/20 0.45
▸ PIK3CD O00329 1/20 0.44
▸ PIK3CA P42336 1/20 0.44
▸ PIK3CG P48736 1/20 0.44
▸ NOTUM Q6P988 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25420456 0.81 ALDH1A1 (0.68) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL5593071 0.80 LMNA (0.56) ALDH1A1L3MBTL1LMNAIDO1CTSS
SCHEMBL3557728 0.79 LMNA (0.55) ALDH1A1GAAL3MBTL1LMNAIDO1
SCHEMBL11467792 0.79 LMNA (0.58) ALDH1A1GAAL3MBTL1LMNAIDO1
SCHEMBL11114941 0.78 ALDH1A1 (0.62) ALDH1A1CYP1A2GAACYP2C9CYP2C19
SCHEMBL3398455 0.78 ADORA2A (0.56) CYP1A2CYP2C9CYP2C19IDO1CTSS
SCHEMBL3874359 0.78 LMNA (0.54) ALDH1A1CYP1A2GAAL3MBTL1LMNA
SCHEMBL11265993 0.78 F2RL3 (0.47) ALDH1A1CYP1A2GAALMNAIDO1
SCHEMBL1357676 0.78 LMNA (0.54) ALDH1A1GAAL3MBTL1LMNAIDO1
SCHEMBL3874666 0.78 LMNA (0.54) ALDH1A1CYP1A2GAACYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 — — US claimed
US-4310551-A Pharmacologically active substituted 1,2,4-triazines DIAMOND SHAMROCK CORPORATION (US) 1982-01-12 — — US disclosed
US-4251527-A ANTIINFLAMMATORY AGENTS DIAMOND SHAMROCK CORPORATION (US) 1981-02-17 — — US disclosed
US-4159375-A 6- AND 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines AMERICAN CYANAMID COMPANY (US) 1979-06-26 — — US disclosed
US-4157392-A HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS AND NERVOUS SYSTEM EFFECTS DIAMOND SHAMROCK CORPORATION (US) 1979-06-05 — — US disclosed
Send feedback